⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | LIC MF Manufacturing Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | LIC MF | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹11.05 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | Nifty India Manufacturing - TRI | BSE Health Care - TRI |
| Fund Manager | Mahesh Bendre | Nikhil Mathur |
| Inception | 11 Oct 2024 | 04 Oct 2023 |
| Returns | ||
| 1Y | 6.82% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 5.43% | 29.15% |
| Risk | ||
| 19.08 | 14.07 | |
| 1.10 | 0.59 | |
| 0.26 | 1.59 | |
| 5.35 | 21.67 | |
| 0.52 | 3.48 | |
| -12.79% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.50% | 1.03% |
| Exit Load | Nil upto 12% of units and 1% for remaining units on or before 90D, Nil after 90D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹200 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
LIC MF96%
HDFC MF96%
4.3%Only 4.3% of holdings by weight are common between LIC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingLIC MFHDFC MF
Sun Pharmaceutical Industries Ltd.2.22%8.28%
Cipla Ltd.2.08%4.15%
Category context: Equity vs Equity. Open the full Screener →